TATVA1,655.00

Tatva Chintan Pharma Chem Limited

· Chemicals
AnnualQuarterly₹ CrorePeersVISHNUJUBLCPLKIRIINDUSFOSECOINDCHEMPLASTSDDEVPLSTIKGUJALKALIYASHOMcap ₹3,871 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations393.5382.7505.9556.0
Other Income7.52.33.55.2
Total Income401.0385.0509.4561.2
Expenses
+ Cost of Materials Consumed178.8173.8262.8304.3
+ Purchases of Stock-in-Trade3.63.06.56.6
+ Changes in Inventories-8.222.2-44.7-69.4
+ Employee Benefit Expense54.852.962.965.6
+ Finance Costs6.51.32.94.5
+ Depreciation & Amortisation25.627.736.838.4
+ Other Expenses96.496.6125.2140.9
Total Expenses357.4377.5452.4490.9
EBITDA68.234.293.2108.1
EBIT42.66.656.369.7
Profit
PBT before Exceptional Items43.67.657.070.3
+ Exceptional Items0.00.00.0-1.3
Pretax Income43.67.657.069.0
+ Current Tax7.61.512.011.1
+ Deferred Tax5.60.33.06.5
Tax Expense13.21.915.017.6
Net Income30.45.742.151.4
+ Net Income — Continuing Ops30.45.742.151.4
+ Other Comprehensive Income0.00.73.22.3
Total Comprehensive Income30.46.445.353.7
Net Income to Common30.45.742.151.4
Per Share
Basic EPS13.262.4417.9821.97
Diluted EPS13.262.4417.9821.97
Other Comprehensive Income — detail
+ Other Comprehensive Income0.73.22.3
+ Items NOT to be Reclassified to P&L-0.2-0.30.20.4
+ Tax on Items NOT to be Reclassified-0.10.10.1
+ Tax on Items NOT to be Reclassified — alt tag-0.1
+ Items to be Reclassified to P&L0.20.93.02.0
Comprehensive Income — Owners of Parent30.46.445.353.7
Per Share — as-filed variants
Basic EPS — Continuing Operations13.262.4417.9821.97
Diluted EPS — Continuing Operations13.262.4417.9821.97
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit219.3183.8281.3314.6
Gross Margin %55.7448.0255.6156.57
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)43.67.657.070.3
− Exceptional Items (reconciliation)0.00.00.0-1.3
Net Income Adj (tax-effected)30.45.742.152.4
EPS Adj13.262.4417.9822.39
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital23.423.423.423.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.